$CABA
Cabaletta Bio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Cabaletta Bio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CABA down today? It is at $1.02 (-2.84%), and our scanner flagged it 192 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CABA spikes, and full due diligence on CABA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CABA 192 times in the last 30 days. Create a free account to track $CABA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CABA from our scanner (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on CABA today, peaking at 22.8x its normal volume.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 16, 2026 · 3 days agoAcross every filing on file, supply equal to 498.1% of the tradeable float is in play - 498.1% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
51,725,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $2.9/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Gerard Michael Officer | Bought (open market) | +7K | n/a | 7K | $15K at $2.27 | Jan 21, 26 |
Simon Mark Director | Bought (open market) | +11K | added 8.1% | 147K | $25K at $2.28 | Jan 21, 26 |
Nichtberger Steven Officer | Bought (open market) | +45K 0.02% of company | added 4.6% | 1.03M | $101K at $2.24 | Jan 21, 26 |
Bollard Catherine Director | Bought (open market) | +4K | added 100% | 5K | $10K at $2.27 | Jan 21, 26 |
Gavel Steve Officer | Bought (open market) | +22K 0.01% of company | n/a | 22K | $50K at $2.27 | Jan 21, 26 |
Tomasello Shawn Director | Bought (open market) | +23K 0.01% of company | n/a | 23K | $50K at $2.21 | Jan 21, 26 |
Binder Gwendolyn Officer | Bought (open market) | +11K | added 57% | 31K | $25K at $2.19 | Jan 21, 26 |
Chang David J. Officer | Bought (open market) | +9K | n/a | 9K | $20K at $2.26 | Jan 21, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on CABA from our scanner (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on CABA today, peaking at 22.8x its normal volume.
CABA last traded at $1.02, down 2.84% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CABA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CABA 192 times in the last 30 days.
CABA (Cabaletta Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $228M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CABA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CABA discussion
Sign in to ask a question or join the discussion.